Intrinsic Therapeutics
Woburn, US · Delaware corporation · 5 known investors
Barricaid develops a bone-anchored implant designed to reduce reherniation and reoperation in patients undergoing discectomy for large annular defects. The device is marketed to physicians and patients with lumbar disc herniation.
Founders & leadership
JD
Jeani DelagardelleDirector
GH
Gregory H. LambrechtDirector
BV
Brian VerrierDirector
JM
Joshua MakowerDirector
CH
Carey HaganExecutive Officer, Director
KS
Kevin SidowDirector
RD
Ryan DrantDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$55.5MraisedDec 2023 · 9 investors · Other Health CareRule 506(b)
▶$55.5MraisedDec 2023 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeani DeagardellelDirector
- Gregory H. LambrechtDirector
- Ryan DrantDirector
- Cary HaganExecutive Officer, Director
- Peter PizzoExecutive Officer
- Brian VerrierDirector
- Offering amount
- $68.5M
- Amount sold
- $55.5M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.5MraisedAug 2023 · 18 investors · Other Health CareRule 506(b)
▶$5.5MraisedAug 2023 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin SidowDirector
- Gregory H. LambrechtDirector
- Ryan DrantDirector
- Brian VerrierDirector
- Peter PizzoExecutive Officer
- Jeani DelagardelleDirector
- Cary HaganExecutive Officer, Director
- Offering amount
- $5.5M
- Amount sold
- $5.5M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.9MraisedApr 2023 · 9 investors · Other Health CareRule 506(b)
▶$5.9MraisedApr 2023 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brian VerrierDirector
- Gregory LambrechtDirector
- Kevin SidowDirector
- Jeani DelagardelleDirector
- Ryan DrantDirector
- Cary HaganExecutive Officer, Director
- Offering amount
- $7.5M
- Amount sold
- $5.9M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$38.4MraisedApr 2021 · 13 investors · Other Health CareRule 506(b)
▶$38.4MraisedApr 2021 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan DrantDirector
- Jeani DelagardelleDirector
- Gregory H. LambrechtDirector
- Brian VerrierDirector
- Joshua MakowerDirector
- Carey HaganExecutive Officer, Director
- Kevin SidowDirector
- Offering amount
- $40M
- Amount sold
- $38.4M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$38.8MraisedApr 2019 · 28 investors · Other Health CareRule 506(b)
▶$38.8MraisedApr 2019 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan DrantDirector
- Joshua MakowerDirector
- Brian VerrierDirector
- Kevin SidowDirector
- Jeani DelagardelleDirector
- Gregory H LambrechtExecutive Officer, Director
- Cary HaganExecutive Officer, Director
- Kevin ConnorsDirector
- Offering amount
- $41.7M
- Amount sold
- $38.8M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$28.4MraisedMar 2017 · 22 investors · Other Health CareRule 506(b)
▶$28.4MraisedMar 2017 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gregory H LambrechtExecutive Officer, Director
- Cary HaganExecutive Officer, Director
- Ryan DrantDirector
- Kevin SidowDirector
- Brian VerrierDirector
- Jeani DelagardelleDirector
- Kevin ConnorsDirector
- Joshua MakowerDirector
- Offering amount
- $28.4M
- Amount sold
- $28.4M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Intrinsic Therapeutics Announces Initial Release of Its Next Generation Barricaid Narrow Anchor Device Designed to Reduce Reherniation After Back Surgeryprnewswire.com · 2026
- Intrinsic Therapeutics raises $52m for Barricaid annulus seal - MassDevicemassdevice.com · 2019
- Intrinsic Therapeutics Completes $52m Financing to Fuel Commercial Efforts in the United States to Benefit Lumbar Discectomy Patientsprnewswire.com · 2019
- Intrinsic Therapeutics Completes $52M Financing - FinSMEsfinsmes.com · 2019
- Intrinsic Therapeutics lands $11.6M in new funding for treatment of herniated lumbar discs -orthostreams.com · 2012